Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes Without Del(5Q): Results of a Phase Iii Trial

AuthID
P-00Q-KVB
9
Author(s)
Garcia Manero, G
·
Fenaux, P
·
Gattermann, N
·
Giagounidis, A
·
Goldberg, SL
·
Ozawa, K
·
Weaver, J
·
Santini, V
Document Type
Article
Year published
2019
Published
in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, ISSN: 2152-2650
Volume: 19, Issue: 4, Pages: 213-+ (11)
Indexing
Publication Identifiers
Pubmed: 30770308
Scopus: 2-s2.0-85061331077
Wos: WOS:000467597900009
Source Identifiers
ISSN: 2152-2650
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.